- Adjunct Associate Professor, Global Health
- Associate Professor, Medicine - Allergy and Infectious Dis.
- Program Director, UW Global Health HIV/STI Graduate Certificate Program
325 Ninth Avenue, Box 359930
Seattle, WA 98115
Select from the following:
Dr. Kim works as a clinician-educator at the Harborview (HMC) Hepatitis & Liver Clinic and at the HMC Madison (HIV) Clinic. She is the Director of the Madison HIV/Hepatitis Coinfection Clinic. She serves as Associate Editor for Hepatitis C Online, a CDC-sponsored web-based curriculum and directs Global Health 573 , a UW graduate-level course entitled "Clinical Management of HIV," which is offered to both local and international students. She is the academic director of the UW HIV/STI Graduate Certificate program.
Dr. Kim is the lead investigator for the Liver Disease section of the UW Center for AIDS Research Clinical Epidemiology & Health Services Research Core. Her research has included work on chronic hepatitis B and hepatitis B vaccination in HIV-infected patients. Her current research is focused on clinical predictors of liver disease progression in HIV-infected patients.
- MD (University of California (San Francisco))
- MSc (University of Washington)
- BA (Harvard University)
- Education and Training
Kim HN, Nance R, Van Rompaey S, Delaney JC, Crane HM, et al. Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis. J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):437-43. PubMed PMID: 26990826
Kim HN, Rodriguez CV, Van Rompaey S, Eron JJ, Thio CL, et al. Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort. J Acquir Immune Defic Syndr. 2014 May 1;66(1):96-101. PubMed PMID: 24500175
Chung MH, Severynen AO, Hals MP, Harrington RD, Spach DH, et al. Offering an American graduate medical HIV course to health care workers in resource-limited settings via the Internet. PLoS One. 2012;7(12):e52663. PubMed PMID: 23285139
Kim HN, Scott J, Cent A, Cook L, Morrow RA, et al. HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya. J Viral Hepat. 2011 Oct;18(10):e447-52. PubMed PMID: 21914062